Ankerst DP - Search Results

1

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.

Parekh DJ, Ankerst DP, Higgins BA, Hernandez J, Canby-Hagino E, Brand T, Troyer DA, Leach RJ, Thompson IM. Parekh DJ, et al. Among authors: ankerst dp. Urology. 2006 Dec;68(6):1152-5. doi: 10.1016/j.urology.2006.10.022. Urology. 2006. PMID: 17169636

2

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA Jr. Thompson IM, et al. Among authors: ankerst dp. JAMA. 2005 Jul 6;294(1):66-70. doi: 10.1001/jama.294.1.66. JAMA. 2005. PMID: 15998892

3

Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.

Etzioni RD, Howlader N, Shaw PA, Ankerst DP, Penson DF, Goodman PJ, Thompson IM. Etzioni RD, et al. Among authors: ankerst dp. J Urol. 2005 Sep;174(3):877-81. doi: 10.1097/01.ju.0000169255.64518.fb. J Urol. 2005. PMID: 16093979 Clinical Trial.

4

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr. Thompson IM, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2006 Apr 19;98(8):529-34. doi: 10.1093/jnci/djj131. J Natl Cancer Inst. 2006. PMID: 16622122

5

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM. Baillargeon J, et al. Among authors: ankerst dp. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5. doi: 10.1158/1055-9965.EPI-06-0082. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835332

6

Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr. Thompson IM, et al. Among authors: ankerst dp. J Natl Cancer Inst. 2006 Aug 16;98(16):1128-33. doi: 10.1093/jnci/djj307. J Natl Cancer Inst. 2006. PMID: 16912265 Clinical Trial.

7

Understanding mixed messages about prostate specific antigen: biases in the evaluation of cancer biomarkers.

Ankerst DP, Thompson IM. Ankerst DP, et al. J Urol. 2007 Feb;177(2):426-7. doi: 10.1016/j.juro.2006.11.009. J Urol. 2007. PMID: 17222602 No abstract available.

8

Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification.

Ankerst DP, Thompson IM. Ankerst DP, et al. Arch Ital Urol Androl. 2006 Dec;78(4):125-9. Arch Ital Urol Androl. 2006. PMID: 17269614 Clinical Trial.

9

Merging digital rectal exam, family history, age and prostate-specific antigen to create a decision-making tool.

Ankerst DP, Thompson IM. Ankerst DP, et al. Arch Ital Urol Androl. 2006 Dec;78(4):143-6. Arch Ital Urol Androl. 2006. PMID: 17269618

10

New answers from the Prostate Cancer Prevention Trial on the chemoprevention of prostate cancer.

Ankerst DP, Thompson IM. Ankerst DP, et al. Arch Ital Urol Androl. 2006 Dec;78(4):154-6. Arch Ital Urol Androl. 2006. PMID: 17269622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters